Biotia Launches Clinically Approved Drug Resistance Reporting for Complicated UTIs, Backed by Second Consecutive CAMDA Win

BIOTIA-DX Resistance is now available for clinical use through the New York State CLEP-approved BIOTIA-ID Urine Test, delivering rapid antimicrobial resistance profiling for patients with recurrent or complicated urinary tract infections. NEW YORK, May 19, 2026 /PRNewswire/ -- Biotia, a...